Home » Trials


Trials

 

Trial Title Registration Number Flag

Optimizing Care for Patients with Depression: A Randomized Controlled Trial of Pharmacist Interventions to Enhance Adherence, Outcomes, and Satisfaction in a Tertiary Sri Lankan

SLCTR/2026/003

Effectiveness of the Instructional Sequence of Role Play and Lecture versus Lecture and Role Play in Developing Health Communication Competence in managing aggressive patients empathetically among Nurses: A Hospital-Based Parallel-Group Randomized Controlled Trial

SLCTR/2026/002

EFFECTIVENESS OF MYOFASCIAL RELEASE, MUSCLE ENERGY TECHNIQUE, AND TENS ON PAIN, RANGE OF MOTION, FUNCTIONAL STATUS, AND QUALITY OF LIFE IN ADULTS WITH CHRONIC NON-SPECIFIC NECK PAIN: A RANDOMIZED CONTROLLED TRIAL

SLCTR/2026/001

Effectiveness of Yoga Exercise on Glycemic Indicator, Anthropometry and Quality of Life of the Middle-aged Community in the Colombo District – A Stepped Wedge Cluster Randomized Trial

SLCTR/2025/043

Clinical Application of Autologous Adipose Stem Mitochondria Transplantation to Oocytes for Improving Embryo Quality in Patients with Recurrent Pregnancy Failure

SLCTR/2025/042

Effect of the consumption of Sri Lankan black tea on blood lipids: A randomized controlled trial

SLCTR/2025/041

A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient s current antipsychotic medication(s)

SLCTR/2025/040

Impact of Isoflurane and Desflurane on Recovery Time and Postoperative Nausea in Patients Undergoing Laparoscopic Cholecystectomy

SLCTR/2025/039

A randomized, double-blind, placebo-controlled pragmatic study to evaluate FINerenone on clinicAL effIcacy and safeTY in patients with Heart Failure and reduced ejection fraction who are intolerant of or not eligible for treatment with steroidal mineralocorticoid receptor antagonists (FINALITY-HF)

SLCTR/2025/038

The Chronic kidney disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect (CAPTIVATE)

SLCTR/2025/037

- Protocol changed - Trial completed - Progress reports not updated - Retrospective trial - Duplicate registration